Skip to main content
Premium Trial:

Request an Annual Quote

Cigna Issues Positive Coverage Decision for MDxHealth Prostate Cancer Test

NEW YORK (GenomeWeb) – Belgian molecular diagnostics developer MDxHealth announced today that it has received a positive medical policy decision from Cigna for its ConfirmMDx prostate cancer test.

Cigna's decision follows the test's recent inclusion in the US 2016 National Comprehensive Cancer Network (NCCN) Guidelines for prostate cancer screening. "Tests that improve specificity in the post-biopsy state — including 4Kscore, PHI, percent free PSA, PCA3, and ConfirmMDx — should be considered in patients thought to be higher risk despite a negative prostate biopsy," the NCCN guidelines now say.

ConfirmMDx is an epigenetic tissue-based test for the early detection of prostate cancer, specifically aimed at addressing false-negative biopsy concerns. Nearly 2,800 urologists have ordered the test to date, MDxHealth added, and it has qualified for Medicare, Medicare Advantage, and other private reimbursement plans.

"Cigna's positive medical policy is another major milestone for our ConfirmMDx for Prostate Cancer test," said MDxHealth CEO Jan Groen in a statement. "We are seeing increasing recognition and adoption of ConfirmMDx to improve patient outcomes and manage rising healthcare costs among the urology and managed care communities."

In June, the company announced that ConfirmMDx would be covered by Michigan-based health plan Priority Health for all of its nearly 720,000 members.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.